Web NewDrugInformation.com

Nitrolingual Drug - Nitrolingual The trade name of the product as shown on the labeling. Dosage - AEROSOL; SUBLINGUAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Nitroglycerin Multiple ingredients are in alphabetical order. Strength - 0.4MG/SPRAY The potency of the active ingredient(s), Nitroglycerin. May repeat for multiple part products. Applicant - POHL BOSKAMP The firm name holding legal responsibility for Nitrolingual. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 018705 The FDA assigned number to Nitrolingual. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Nitrolingual. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Oct 31, 1985 The date Nitrolingual was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Nitrolingual. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - DISCN The group or category of approved drugs Nitrolingual is in. Format is RX, OTC, DISCN. Applicant Full Name - G Pohl Boskamp Gmbh And Co The full name of the firm holding legal responsibility for the new application of Nitrolingual. Nitrolingual Nitrofurazone 0.2% Ointment; Topical Nitrofurazone 0.2% Ointment; Topical Nitrofurazone 0.2% Ointment; Topical Furacin 0.2% Powder; Topical Nitrofurazone 0.2% Solution; Topical Nitrofurazone 0.2% Solution; Topical Nitrolingual 0.4mg/spray Aerosol; Sublingual Furacin 0.2% Ointment; Topical Nitrofurazone 0.2% Ointment; Topical Nitrofurazone 0.2% Ointment; Topical NewDrugInformation